知镜 Cognispect · 医学文献与研究工作台

Costs of two-step MASLD screening using ALT and elastography in children with overweight and obesity.

Stroes AR, Muntjewerff E, Draijer L, Chegary M, Kreier F, van Os E, Goede J, Boonstra V, Westerbeek I, Bouma S, Kusters DM, Roelants R, Beuers U, Holleboom AG, Benninga MA, Koot BGP.
Obesity research & clinical practice · 2026-10-09 · PMID 42855326

文献摘要

Objectives Metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent among children with obesity. Although screening is widely performed in pediatric obesity-related comorbidity assessment, evidence on effectiveness and costs is lacking. This study quantifies costs of MASLD screening using ALT and vibration-controlled transient elastography (VCTE) in children with overweight and obesity. Methods We prospectively analyzed costs of a two-step MASLD screening strategy in obesity clinics in the Amsterdam region. Children with overweight and obesity underwent ALT testing; those with elevated ALT were referred for further assessment according to MASLD guidelines. Healthcare and societal costs were calculated per child screened and per advanced MASLD case detected (VCTE ≥7.4 kPa). Scenario 1 included limited additional testing for other liver disorders and scenario 2 more elaborate testing. Results In a screened population of 2376 children, healthcare costs were €144 per child screened and €5608 per advanced MASLD case detected; healthcare and societal costs combined were €201 per child screened and €7822 per case detected. Scenario 2 increased healthcare costs by 15%. Conclusions This study provides novel cost data on pediatric MASLD screening, which may inform policy and implementation strategies for children with overweight and obesity.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。